Bluejay Diagnostics, Inc. Common Stock (BJDX) Stock Price

BJDXStock

$0.92−83.81%52W

Market Cap$948,005.883

P/E—

PEG Ratio—

Div yield—

Beta0.96

BJDX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-75.67%

Price vs S&P 500 (4W)-13.03%

VGM Score4.84

Book Value / Share (Quarterly)$4.04

P/TBV (Annual)0.33x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-6.43

Price vs S&P 500 (YTD)-78.24%

EPS (TTM)$-53.96

10-Day Avg Trading Volume0.31M

EPS Excl Extra (TTM)$-53.96

EPS (Annual)$-61.01

ROI (Annual)-114.43%

Gross Margin (Annual)20.00%

Cash / Share (Quarterly)$3.56

ROA (Last FY)-96.20%

Revenue Growth TTM (YoY)-100.00%

EBITD / Share (TTM)$-15.74

ROE (5Y Avg)-138.17%

Cash Flow / Share (Annual)$-41.21

P/B Ratio0.26x

P/B Ratio (Quarterly)0.46x

Net Income / Employee (Annual)$-1,141,400

Net Interest Coverage (TTM)-10.40x

ROA (TTM)-115.00%

EPS Incl Extra (Annual)$-61.01

Current Ratio (Annual)4.88x

Quick Ratio (Quarterly)2.62x

3-Month Avg Trading Volume4.14M

52-Week Price Return-83.81%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$4.21

P/S Ratio (Annual)4.39x

Asset Turnover (Annual)0.02x

52-Week High$16.68

EPS Excl Extra (Annual)$-61.01

CapEx CAGR (5Y)98.32%

26-Week Price Return-64.42%

Quick Ratio (Annual)4.64x

13-Week Price Return-53.84%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.81x

Enterprise Value$-2.58M

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-3720.00%

Cash / Share (Annual)$34.18

3-Month Return Std Dev264.52%

Net Income / Employee (TTM)$-1,150,500

ROE (Last FY)-114.61%

Net Interest Coverage (Annual)-3.84x

EPS Basic Excl Extra (Annual)$-61.01

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-53.96

ROI (TTM)-143.98%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$11.42

Price vs S&P 500 (52W)-102.12%

Year-to-Date Return-66.28%

5-Day Price Return-7.21%

EPS Normalized (Annual)$-61.01

ROA (5Y Avg)-100.39%

Net Profit Margin (Annual)-3720.00%

Month-to-Date Return4.67%

Cash Flow / Share (TTM)$-9.03

EBITD / Share (Annual)$-61.28

Operating Margin (Annual)-3824.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-137.64%

LT Debt / Equity (Quarterly)0.25x

EPS Basic Excl Extra (TTM)$-53.96

P/TBV (Quarterly)0.73x

P/B Ratio (Annual)0.20x

Book Value / Share (Annual)$39.54

Price vs S&P 500 (13W)-56.63%

Beta0.96x

Revenue / Share (TTM)$0.00

ROE (TTM)-144.27%

52-Week Low$0.83

gGradeF

mGradeF

vgmGradeF

BJDX Earnings Surprise History

Q2 23-4400.00est. -2240.00

Q3 23-3328.00est. -1344.00

Q4 23-2848.00est. -1360.00

BJDX Analyst Recommendations

Apr 2024

May 2024

Jun 2024

Jul 2024

2.17

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
BJDXBluejay Diagnostics, Inc. Common Stock	—	F	F	$0.92
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Bluejay Diagnostics, Inc. Common Stock

Bluejay Diagnostics develops the Symphony System, a rapid, cost-effective near-patient testing platform for sepsis diagnosis and monitoring. Its first product, an IL-6 sepsis test, delivers results in approximately 20 minutes, enabling faster clinical decision-making and improved patient outcomes. The platform addresses a critical clinical need in acute care settings where rapid sepsis diagnosis is essential for treatment efficacy.